The University of Michigan has launched a new initiative to harness campus-wide research aimed at finding personalized solutions to improve the health and wellness of individuals and communities.

Modern medicine gathers astronomical amounts of information on patients, but has had little sense of how to store, process, or apply it. But now doctors and researchers at the University of Michigan are working across disciplines and in multiple areas of medicine to harness individuals’ stats to develop more precise approaches to care. Hour Detroit looks at precision health research across U-M.

Persistent prescription opioid use may not only be a problem for adult patients. It’s an issue for teens and young adults, too, a new study suggests. Nearly 5 percent of patients ages 13 to 21 who had common surgical procedures continued to receive opioid prescription refills three to six months after surgery.

For using data science to identify hospital patients at risk of contracting an infection they didn’t check in with, Michigan Engineering professor Jenna Wiens has been named to MIT Technology Review’s 2017 list of 35 Innovators Under 35.

The average metastatic cancer has more genetic mutations than are seen in early stage tumors, a new study finds. What that means: To make precision medicine a reality in cancer care, you need a real-time, comprehensive approach that looks at the metastatic tumors and sequences to a level of detail beyond most commercial tests.

A multidisciplinary University of Michigan team has developed a device to quickly assess the immune response in pediatric intensive care patients.The device eventually could be used in ICUs nationwide to help treat children who have developed overwhelming sepsis, for example.

For the first time, researchers connected two different types of DNA snippets to identify individuals. This could help researchers across many fields — but isn’t without risk.